Characterization of patients with colon cancer

Authors

  • Luis Andrés Guibert Adolfo Hospital Militar de camaguey Octavio de la concepcion y la pedraja
  • Luis Ernesto Quiroga Meriño
  • Yarima Estrada Brizuela
  • Osmany Mario Maestre Ramos
  • Germán Guilarte León

Abstract

Background: colon cancer is the third more frequent cause of morbidity and mortality for cancer in the world.
Objective: to characterize the patients with colon cancer.
Methods: a transversal and descriptive study was carried out aimed at characterizing patients with colon cancer in the Service of General Surgery of the Military Hospital Octavio de la Concepción y la Pedraja from October 2013 to August 2017. The universe was compound for 61 patients diagnosed with colon cancer.
Results: women prevailed in the study. Patients older than 60 years were the majority, specifically those from the 70 to 79 age group. The hairy adenoma is the more frequent antecedent followed by the ulcerative colitis. The low digestive bleeding was the form of predominant presentation in the patients and the left localization of the tumor was the most frequent. In most of the patients the colon cancer was well differentiated. The adenocarcinoma is the more frequent histological type.
Conclusions: women prevailed between 70 and 79 years with adenomas as pathological antecedents. Digestive bleeding was the clinical form of more frequent presentation, and it was associated to left localization. A part of the studied patients required surgical intervention and the most used technique was the left hemicolectomy. Most of the neoplasias were well differentiated with chronic inflammation.

DeCS: COLONIC NEOPLASMS/surgery; ADENOCARCINOMA; SPHINCTEROTOMY, ENDOSCOPIC; AGED; CROSS-SECTIONAL STUDIES.

Downloads

Download data is not yet available.

References

1.Zhu H, Zhang G, Yi X, Zhu X, Wu Y, Liang J, et al. Histology subtypes and polyp size are associated with synchronous colorectal carcinoma of colorectal serrated polyps: a study of 499 serrated polyps. Am J Cancer Res [Internet]. 2015 Jan [cited 2015 Dec 24];5(1):[about 12 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300721/.

2.Zhou L, Xie J, Gu EL, Huang Y, Qu Y, Xu AP, et al. Common genetic variant on BMP4 contributes to colorectal adenoma and cancer: A meta-analysis based on 15 studies. Cytokine [Internet]. 2015 Abr [cited 2015 Dec 24];72(2):[about 9 p.]. Available from: http://www.sciencedirect.com/science/article/pii/S1043466614006541

3.Xie J, Dong H, Chen H, Zhao R, Sinko PJ, Shen W, et al. Exploring cancer metastasis prevention strategy: interrupting adhesion of cancer cells to vascular endothelia of potential metastatic tissues by antibody-coated nanomaterial. J Nanobiotechnology [Internet]. 2015 .[cited 2015 Dec 24];13(9):[about 10 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320453/.

4.Vrinten C, Waller J, von Wagner C, Wardle J. Cancer fear: facilitator and deterrent to participation in colorectal cancer screening. Can Epidemiol Biom Prev [Internet]. 2015 [cited 2015 Dec 24];24(2):[about 9 p.]. Available from: http://cebp.aacrjournals.org/content/24/2/400.short

5.Tanday S. Less surgery improves survival for advanced colorectal cancer. Lancet Oncol [Internet]. 2015 Jan [cited 2015 Dec 12];16(3):[about 2 p.]. Available from: http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2814%2971202-1/abstract

6.Tamandl D, Butte JM, Allen PJ, D'Angelica MI, DeMatteo RP, Groeger JS, et al. Hospital readmissions after liver surgery for metastatic colorectal cancer. Surgery [Internet]. 2015 Feb [cited 2015 Dec 24];157(2):[about 10 p.]. Available from: http://www.sciencedirect.com/science/article/pii/S0039606014006096

7.Bachmayr-Heyda A, Reiner AT, Auer K, Sukhbaatar N, Aust S, Bachleitner-Hofmann T, et al. Correlation of circular RNA abundance with proliferation - exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci Rep [Internet]. 2015 Jan [cited 2015 Dec 24]; 8057:[about 12 p.]. Available from: http://www.nature.com/articles/srep08057

8.Choe EK, Park KJ, Chung SJ, Moon SH, Ryoo SB, Oh HK. Colonoscopic surveillance after colorectal cancer resection: who needs more intensive follow-up?. Digestion [nternet]. 2015 [cited 2015 Apr 12];91(2):[about 7 p.]. Available from: http://www.karger.com/Article/FullText/370308

9.Crncec I, Pathria P, Svinka J, Eferl R. Induction of colorectal cancer in mice and histomorphometric evaluation of tumors. Methods Mol Biol [Internet]. 2015 [cited 2015 Jan 14];1267:[about 12 p.]. Available from: http://link.springer.com/protocol/10.1007/978-1-4939-2297-0_7#page-1

10.Sugano K, Maeda K, Ohtani H, Nagahara H, Shibutani M, Hirakawa K. Expression of xCT as a Predictor of Disease Recurrence in Patients with Colorectal Cancer. Anticancer Res [nternet]. 2015 Feb [cited 2015 Apr 12];35(2):[about 9 p.]. Available from: http://ar.iiarjournals.org/content/35/2/677.short#

11.Suenaga M, Mizunuma N, Shinozaki E, Matsusaka S, Ozaka M, Ogura M, et al. Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab. Onco Targets Ther [Internet]. 2015 Feb [cited 2015 Jan 23];8(2):[about 10 p.]. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315555/.

12.Sturludóttir M, Martling A, Carlsson S, Blomqvist L. Synchronous rectal and prostate cancer - The impact of MRI on incidence and imaging findings. Eur J Radiol [Internet]. 2015 Jan [cited 2015 Nov 23];84(4):[about 12 p.]. Available from: http://www.sciencedirect.com/science/article/pii/S0720048X15000194

13.Ferreira Bohórquez EJ, Meléndez Héctor J. Características clínicas, demográficas e histopatológicas de los pacientes con cáncer colorrectal del Hospital Universitario de Santander. Rev Colomb de Cir [Internet]. Jul-Sep 2012 [citado 23 Oct 2015]; 27(3):[aprox. 12 p.]. Disponible en: http://bases.bireme.br/cgi-bin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis&src=google&base=LILACS&lang=p&nextAction=lnk&exprSearch=657000&indexSearch=ID

14.Montes de Oca Megías E, Soler Porro LL, Noa Pedroso G, Agüero Betancourt CdlM, González Gutiérrez JL, Barreto Suárez E. Comportamiento del cáncer colorrectal esporádico en un hospital provincial. Rev cubana med [Internet]. Oct-Dic 2012 [citado 12 Dic 2015];51(4):[aprox 10 p.]. Disponible en: http://www.imbiomed.com.mx/1/1/articulos.php?method=showDetail&id_revista=68&id_seccion=489&id_ejemplar=9195&id_articulo=94017

15.Neuhouser ML, Cheng TY, Beresford SA, Brown E, Song X, Miller JW, et al. Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative Observational Study. Int J Cancer [Internet]. 2015 Aug [cited 2015 Nov 23];137(4):[about 11 p.]. Available from: http://onlinelibrary.wiley.com/doi/10.1002/ijc.29453/full

16.Liu Z, Zhang Y, Franzin L, Cormier JN, Chan W, Xu H, et al. Trends and variations in breast and colorectal cancer incidence from 1995 to 2011: A comparative study between Texas Cancer Registry and National Cancer Institute's Surveillance, Epidemiology and End Results data. Int J Oncol [Internet]. 2015 Apr [cited 2015 Nov 23];46(4):[about 9 p.]. Available from: http://www.spandidos-publications.com/10.3892/ijo.2015.2881

17.Barrera E, Bannura CG, Illanes FF, Esperguel GC, Melo LC. Resultados precoces de la cirugía electiva del cáncer de colon en mayores de 75 años. Rev Chil Cir [Internet]. Feb 2012 [citado 3 Mar 2016];64(1):[aprox.12 p.]. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0718-40262012000100010&lng=es

18.Chacaltana Mendoza A, Rodriguez Ulloa C, Frisancho Velarde O. Valoración de las indicaciones de colonoscopía en la predicción diagnóstica de cáncer de colon. Rev gastroenterol [Internet]. Dic 2011 [citado 3 Mar 2016];31(4):[aprox. 12 p.]. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022- 51292011000400009&lng=es&nrm=iso

19.Juliao Baños F, Agudelo Zapata Y, Yepes Delgado C. Variación en el cuidado de pacientes con Enfermedad Inflamatoria Intestinal (EII): resultado de una encuesta. Rev Colomb Gastr [Internet]. Ene-Mar 2014 [citado3 Mar 2016];29(1):[aprox. 8 p.]. Disponible en: http://www.scielo.org.co/pdf/rcg/v29n1/v29n1a03.pdf

20.Ojima T, Nakamori M, Nakamura M, Katsuda M, Iida T, Hayata K, et al. Laparoscopic combined resection of synchronous gastric and colorectal cancer. Surg Laparosc Endosc Percutan Tech [Internet]. 2015 Feb [cited 2015 Nov 23];25(1):[about 9 p.]. Available from: http://journals.lww.com/surgicallaparoscopy/Abstract/2015/02000/Laparoscopic_Combined_Resection_of_Synchronous.11.aspx

21.Ling C, Wang L, Wang Z, Xu L, Sun L, Yang H, et al. A pathway-centric survey of somatic mutations in chinese patients with colorectal carcinomas. PLoS One [Internet]. Jan 2015 [cited 2015 Nov 23];10(1):[about 8 p.]. Available from: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0116753

22.Loyde KJ De, Harrison JD, Durcinoska I, Shepherd HL, Solomon MJ, Young JM. Which information source is best? Concordance between patient report, clinician report and medical records of patient co-morbidity and adjuvant therapy health information. J Eval Clin Pract [Internet]. 2015 Apr [cited 2015 Nov 23];21(2):[about 7 p.]. Available from: http://onlinelibrary.wiley.com/doi/10.1111/jep.12327/full

23.Eng OS, Melstrom LG, Carpizo DR. The relationship of perioperative fluid administration to outcomes in colorectal and pancreatic surgery: A review of the literature. J Surg Oncol [Internet]. 2015 Mar [cited 2015 Nov 23];111(14):[about 10 p.]. Available from: http://onlinelibrary.wiley.com/doi/10.1002/jso.23857/full

24.Kingham TP, Correa-Gallego C, D'Angelica MI, Gonen M, DeMatteo RP, Fong Y, et al. Hepatic Parenchymal Preservation Surgery: Decreasing Morbidity and Mortality Rates in 4,152 Resections for Malignancy. J Am Coll Surg [Internet]. 2014 Apr [cited 2015 Nov 23];220(4):[about 7 p.]. Available from: http://www.sciencedirect.com/science/article/pii/S1072751514019231

25.Malvezzi M, Bertuccio P, Rosso T, Rota M, Levi F, La Vecchia C, et al. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? Ann Oncol. [Internet]. 2015 Jan [cited 2015 Feb 12];26(4):[about 11 p.]. Available from: https://www.researchgate.net/profile/Matteo_Rota/publication/271595593_European_cancer_mortality_predictions_for_the_year_2015_does_lung_cancer_have_the_highest_death_rate_in_EU_women/links/5586aa3308aef58c039f13e3.pdf

26.Adams SA, Choi SK, Khang L, D AC, Friedman DB, Eberth JM, et al. Decreased Cancer Mortality-to-Incidence Ratios with Increased Accessibility of Federally Qualified Health Centers. J Community Health [Internet]. 2015 Jan [cited 2015 Mar 7];40:[about 9 p.]. Available from: http://link.springer.com/article/10.1007/s10900-014-9978-8#/page-1

27.Anuario Estadístico de Salud [Internet]. La Habana: Ministerio de Salud Pública .1972-2017 [citado 4 Nov 2017]. Mortalidad por Tumores Malignos según localización. 2015-2016 [aprox. 1 pantalla]. Disponible en: http://bvscuba.sld.cu/anuario-estadistico-de-cuba/.

28.Hano García OM, Wood Rodríguez L, Galbán García E, Abreu Vázquez MdR. Factores de riesgo para el cáncer colorrectal. Rev cubana med [Internet]. Abr-Jun 2011 [citado 12 Dic 2015];50(2):[aprox. 4 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232011000200002&nrm=iso

29.Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of Lynch syndrome: 1895-2015. Nat Rev Cancer [Internet]. 2015 Feb [citado 2016 Mar 3];15(3):[about 15 p.]. Available from: http://www.nature.com/nrc/journal/v15/n3/abs/nrc3878.html

30.Larkey LK, McClain D, Roe DJ, Hector RD, Lopez AM, Sillanpaa B, et al. Randomized Controlled Trial of Storytelling Compared to a Personal Risk Tool Intervention on Colorectal Cancer Screening in Low-Income Patients. Am J Health Promot Internet]. 2015 Nov-Dic [cited 5 Feb 2015];30(2):[about 3 p.]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25615708

31.Kwakman R, Cuba EM de, Winter JP de, Hingh IH de, Delis-van Diemen PM, Tijssen M, et al. Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival. Br J Cancer. [Internet]. 2015 Feb [cited 2016 Mar 3];112:[about 9 p.]. Available from: http://www.nature.com/bjc/journal/v112/n5/abs/bjc201518a.html

32.Leake I. Colorectal cancer: Combining drug therapies to improve treatment efficacy in metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol [Internet]. 2015 Feb [cited 2016 Mar 3];12(121):[about 13 p.]. Available from: http://www.nature.com/nrgastro/journal/v12/n3/full/nrgastro.2015.29.html

33.Laskar RS, Talukdar FR, Choudhury JH, Singh SA, Kundu S, Dhar B, et al. Association of HPV with genetic and epigenetic alterations in colorectal adenocarcinoma from Indian population. Tumour Biol [Internet]. 2015 Feb [cited 2016 Mar 3];36:[about 9 p.]. Available from: http://link.springer.com/article/10.1007/s13277-015-3114-y#page-1

34.Karel MJ, Mulligan EA, Walder A, Martin LA, Moye J, Naik AD. Valued life abilities among veteran cancer survivors. Health Expect [Internet]. 2015 Jan [citado 2015 Mar 3];19(1):[about 11 p.]. Available from: http://onlinelibrary.wiley.com/doi/10.1111/hex.12343/full

35.Zanella ER, Galimi F, Sassi F, Migliardi G, Cottino F, Leto SM, et al. IGF2 is an actionable target that identifies a distinct subpopulation of colorectal cancer patients with marginal response to anti-EGFR therapies. Sci Transl Med [Internet]. 2015 Jan [cited 2015 Mar 20];7(272):[about 8 p.]. Available from: http://stm.sciencemag.org/content/7/272/272ra12.short

36.Ying J, Tsujii M, Kondo J, Hayashi Y, Kato M, Akasaka T, et al. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells. Int J Oncol [Internet]. 2015 Jan [cited 2015 Mar 20];46(4):[about 9 p.]. Available from: http://www.spandidos-publications.com/ijo/46/4/1551?text=fulltext

37.Yin DD, Liu ZJ, Zhang E, Kong R, Zhang ZH, Guo RH. Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. Tumour Biol [Internet]. 2015 Feb [cited 2015 Mar 20];36:[about 13 p.]. Available from: http://link.springer.com/article/10.1007/s13277-015-3139-2#page-2

38.Wang L, Shen X, Wang Z, Xiao X, Wei P, Wang Q, et al. A molecular signature for the prediction of recurrence in colorectal cancer. Mol Cancer [Internet]. 2015 Feb [cited 2015 Mar 20];14(22):[about 7 p.]. Available from: http://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-015-0296-2

Downloads

Published

2018-06-02

How to Cite

1.
Guibert Adolfo LA, Quiroga Meriño LE, Estrada Brizuela Y, Maestre Ramos OM, Guilarte León G. Characterization of patients with colon cancer. Arch méd Camagüey [Internet]. 2018 Jun. 2 [cited 2025 Aug. 2];22(3):324-35. Available from: https://revistaamc.sld.cu/index.php/amc/article/view/5552

Issue

Vol. 22 No. 3 (2018)

Section

Original Articles

License

Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.

Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.

(Download Statement of potential conflicts of interest)

The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).

This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/